Streptococcal Infections-API Insights, 2017
[Report Updated: 30-05-2017]

Published by Delve Insight: 30 May 2017 | 84252
Related Topics: FDA

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Streptococcal
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.

India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

DelveInsight’s, Streptococcal Infections -API Insights, 2017 Report describes the current therapeutics that are propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Streptococcal Infections. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent and patent exclusivity information. The research analysis also presents the global sales data till 2016.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• A snapshot of the global Market therapeutics scenario for Streptococcal Infections.

• A review of the marketed products under prescription for Streptococcal Infections, regulatory information and marketing status.

• Coverage of global patent coverage and detailed commentaries on the US patent challenges.

• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

• Product profiles for marketed products for Streptococcal Infections with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

• Coverage of API Manufacturers for Streptococcal Infections drugs in the United States, Europe and Asian Regions with location details.

• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Streptococcal Infections drugs.

• Key discontinued Marketed products.

• Global Sales Figure from 2012-2016.Reasons to Buy

• Evaluate the marketing status and exclusivity details of Streptococcal Infections key products to exploit opportunities for generic drug development opportunities.

• Key players in the pharmaceutical industry.

•Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Streptococcal Infections.

• API intelligence over marketed drugs for Streptococcal Infections and gaining primary intelligence over active ingredients manufacturers across the globe.

• Uncovering opportunities in the rapidly growing the US markets.

Table of Contents
for Streptococcal Infections-API Insights, 2017 [Report Updated: 30-05-2017]

List Of Tables
in Streptococcal Infections-API Insights, 2017 [Report Updated: 30-05-2017]

Streptococcal Infections Therapeutic Market, US, Marketed Drugs by Application Type, 2017

Streptococcal Infections Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017

Streptococcal Infections Therapeutic Market, US, (Year), 2017

Streptococcal Infections Marketed Drugs, API Manufacturers by US DMF Status, 2017

Streptococcal Infections Marketed Drugs, US DMF Status Drug Specific (Number), 2017

Streptococcal Infections Therapeutic Market, Global Sales (in million USD), 2017

Streptococcal Infections Marketed Drugs, API Manufacturers, Global, 2017

Discontinued Drugs for Streptococcal Infections, 2017

List Of Figures, Charts and Diagrams
in Streptococcal Infections-API Insights, 2017 [Report Updated: 30-05-2017]

Streptococcal Infections Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017

Streptococcal Infections Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017

Streptococcal Infections Therapeutic Market, US, (Year), 2017

Streptococcal Infections Marketed Drugs, API Manufacturers by US DMF Status (%), 2017

Streptococcal Infections Marketed Drugs, US DMF Status Drug Specific (Number), 2017

Streptococcal Infections Therapeutic Market, Global Sales (in million USD), 2017

Streptococcal Infections Marketed Drugs, Patent/Exclusivity Expiry (Year), 2017

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

84252 | DII2017API174

Number of Pages

60

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Group A Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 2028
Report Summary"Group A Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 20...
26 Jul 2019 by MIReports USD $5,083 (normally
USD $5,980)
More Info
SAVE 15% today! Group B Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 2028
Report Summary"Group B Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 20...
26 Jul 2019 by MIReports USD $5,083 (normally
USD $5,980)
More Info
SAVE 15% today! 2019 Streptococcal Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Streptococcal Infections Clinical Trials Study” provides com...
24 Apr 2019 by VPA Research USD $1,529 (normally
USD $1,799)
More Info
SAVE 15% today! Streptococcal Infections Global Clinical Trials Review, H2, 2018
Streptococcal Infections Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial r...
31 Aug 2018 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Dr...
30 May 2017 by Delve Insight USD $1,700 (normally
USD $2,000)
More Info
SAVE 15% today! Streptococcal Pneumonia - Pipeline Review, H2 2016
Streptococcal Pneumonia - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutic...
21 Dec 2016 by Global Markets Direct USD $1,700 (normally
USD $2,000)
More Info
SAVE 15% today! Ampicillin Market Analysis: by Applications (Respiratory Tract Infection, Urinary Tract Infection, Meningitis, Salmonella Infections, Endocarditis, Others (Group 3 Streptococcal Infection, etc.)) Intake Method (by Mouth, by Injection into a Muscle, Intravenously) Target Bacteria Type (Gram Positive Bacteria, Gram Negative Bacteria)-Forecast(2016-2021)
Ampicillin, a semi-synthetic derivative of penicillin, causes cell death by interfering directly wit...
25 Jan 2016 by USD $4,463 (normally
USD $5,251)
More Info
SAVE 15% today! Streptococcal Infections Global Clinical Trials Review, H2, 2015
Streptococcal Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial r...
30 Dec 2015 by Global Data USD $2,125 (normally
USD $2,500)
More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...